Приказ основних података о документу
HPLC determination of lorazepam and lorazepam-related compounds in pharmaceutical formulations
dc.creator | Orlović, D | |
dc.creator | Radulović, D | |
dc.creator | Ivanović, D | |
dc.creator | Vujić, Zorica | |
dc.date.accessioned | 2019-09-02T10:52:23Z | |
dc.date.available | 2019-09-02T10:52:23Z | |
dc.date.issued | 2000 | |
dc.identifier.issn | 0009-5893 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/254 | |
dc.description.abstract | A sensitive, accurate and reproducible high performance liquid chromatographic (HPLC) procedure has been developed for the separation and analysis of lorazepam and related compounds. A 20-muL sample was separated by reversed-phase HPLC on a 150 mm x 4.6 mm, 5-mum particle, Wakosil column with 0.1 M ammonium acetate (pH adjusted to 6.0 with acetic acid)-acetonitrile-methanol, 1:1:1 (v/v) as mobile phase. | en |
dc.publisher | Vieweg, Wiesbaden | |
dc.rights | restrictedAccess | |
dc.source | Chromatographia | |
dc.title | HPLC determination of lorazepam and lorazepam-related compounds in pharmaceutical formulations | en |
dc.type | article | |
dc.rights.license | ARR | |
dcterms.abstract | Вујић, Зорица; Орловић, Д; Радуловић, Д; Ивановић, Д; | |
dc.citation.volume | 52 | |
dc.citation.issue | 11-12 | |
dc.citation.spage | 732 | |
dc.citation.epage | 734 | |
dc.citation.other | 52(11-12): 732-734 | |
dc.citation.rank | M22 | |
dc.identifier.wos | 000166274600008 | |
dc.identifier.doi | 10.1007/BF02490997 | |
dc.identifier.scopus | 2-s2.0-0034523174 | |
dc.type.version | publishedVersion |